Latest & greatest articles for cardiovascular disease

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cardiovascular disease or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cardiovascular disease and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cardiovascular disease

781. Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. (Abstract)

Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. Some experts propose C-reactive protein (CRP) as a screening tool for prediction of cardiovascular disease (CVD). Many epidemiologic studies show positive associations between elevated CRP levels and incident CVD. Assessment of the value of new prognostic tests, however, must rely on understanding of test characteristics rather than on associations measured by relative risks. In the case of CRP

2006 Annals of Internal Medicine

782. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. (Abstract)

Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Adults with diabetes are thought to have a high risk of cardiovascular disease (CVD), irrespective of their age. The main aim of this study was to find out the age at which people with diabetes develop a high risk of CVD, as defined by: an event rate equivalent to a 10-year risk of 20% or more; or an event rate equivalent

2006 Lancet

783. Depression and cardiovascular disease: healing the broken-hearted. Full Text available with Trip Pro

Depression and cardiovascular disease: healing the broken-hearted. Major depressive disorder is a risk factor for the development of incident coronary heart disease events in healthy patients and for adverse cardiovascular outcomes in patients with established heart disease. Depression is present in 1 of 5 outpatients with coronary heart disease and in 1 of 3 outpatients with congestive heart failure, yet the majority of cases are not recognized or appropriately treated. It is not known whether (...) treating depression improves cardiovascular outcomes, but antidepressant treatment with selective serotonin reuptake inhibitors is generally safe, alleviates depression, and improves quality of life. This article evaluates the importance of major depression in patients with cardiovascular disease, and provides practical guidance for identifying and treating this disorder.

2006 JAMA

784. Personality, lifestyle, and risk of cardiovascular disease and cancer: follow-up of population based cohort. Full Text available with Trip Pro

Personality, lifestyle, and risk of cardiovascular disease and cancer: follow-up of population based cohort. To study the relation between measures of personality and risk of cardiovascular disease and cancer in a large cohort.Follow-up of population based cohort.Heidelberg, Germany.5114 women and men aged 40-65 in 1992-5.Psychological traits assessed by several standardised personality questionnaires in 1992-5, related to cause of death (to 2002-3) or reported incidence of cardiovascular (...) for common chronic diseases, probably by affecting unmeasured health related behaviour. The other personality traits assessed had no major impact on cardiovascular disease and cancer.

2006 BMJ

785. Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease. (Abstract)

Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease. Psychosocial factors have been linked to coronary events, but the mechanisms underlying these associations have not been established. Evidence is mixed regarding associations of psychosocial factors with subclinical coronary atherosclerosis.To examine associations of 4 psychosocial factors (depressive symptoms, anger, anxiety, and chronic stress) with the presence of subclinical coronary (...) atherosclerosis.Cross-sectional study.The Multiethnic Study of Atherosclerosis, a population-based study of subclinical atherosclerosis.A multiethnic sample of 6789 adults, 45 to 84 years of age, with no history of clinical cardiovascular disease.Coronary calcium was assessed by using chest computed tomography, and psychosocial factors were assessed by using questionnaires with validated scales.There was no evidence that higher levels of the psychosocial measures were associated with greater prevalence

2006 Annals of Internal Medicine

787. Trandolapril did not reduce cardiovascular death or other events in stable coronary artery disease Full Text available with Trip Pro

Trandolapril did not reduce cardiovascular death or other events in stable coronary artery disease Trandolapril did not reduce cardiovascular death or other events in stable coronary artery disease | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Trandolapril did not reduce cardiovascular death or other events in stable coronary artery disease Article Text Therapeutics Trandolapril did not reduce cardiovascular death or other events

2006 Evidence-Based Medicine

788. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. Full Text available with Trip Pro

Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. Aerobic fitness, an important predictor of cardiovascular disease and mortality, is difficult to assess by maximal exercise testing in older adults. Extended walking tests have been examined as outcome predictors in medically ill populations but not in community-dwelling older adults.To determine whether an extended walking test predicts poor outcomes in older (...) adults.Observational cohort study enrolling 3075 community-dwelling adults aged 70 to 79 years living in Pittsburgh, Pa, or Memphis, Tenn. Of those participating in the Health, Aging, and Body Composition Study, 1584 (52%) were women and 1281 (42%) were black. Participants enrolled from March 1997 to April 1998. Ability to complete the long-distance corridor walk and total performance time was assessed at the baseline examination.Total mortality, incident cardiovascular disease, incident mobility limitation

2006 JAMA

789. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. Full Text available with Trip Pro

and 70.The relations of the metabolic syndrome defined by the national cholesterol education programme (NCEP) of the US National Heart, Lung, and Blood Institute or criteria of the World Health Organization (WHO) to subsequent total and cardiovascular mortality.When adding the metabolic syndrome to models with established risk factors for cardiovascular disease (smoking, diabetes, hypertension, and serum cholesterol) at age 50, presence of the metabolic syndrome as defined in the NCEP significantly (...) predicted total and cardiovascular mortality (Cox proportional hazard ratios 1.36, 95% confidence interval 1.17 to 1.58; and 1.59, 1.29 to 1.95, respectively). The metabolic syndrome added prognostic information to that of the established risk factors for cardiovascular disease (likelihood ratio tests, P < 0.0001 for both outcomes). Similar results were obtained in a subsample without diabetes or manifest cardiovascular disease.In a large, community based sample of middle aged men, the presence

2006 BMJ

790. Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus Full Text available with Trip Pro

Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus Article Text Therapeutics Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus Free Apoor S Gami , MD

2006 Evidence-Based Medicine

791. Haemoglobin A1c concentrations were associated with increased cardiovascular disease and all cause mortality Full Text available with Trip Pro

Haemoglobin A1c concentrations were associated with increased cardiovascular disease and all cause mortality Haemoglobin A1c concentrations were associated with increased cardiovascular disease and all cause mortality | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Haemoglobin A1c concentrations were associated with increased cardiovascular disease and all cause mortality Article Text Aetiology Haemoglobin A 1c concentrations were associated

2006 Evidence-Based Medicine

792. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. Full Text available with Trip Pro

Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. Evidence on the health risks associated with short-term exposure to fine particles (particulate matter < or =2.5 microm in aerodynamic diameter [PM2.5]) is limited. Results from the new national monitoring network for PM2.5 make possible systematic research on health risks at national and regional scales.To estimate risks of cardiovascular and respiratory hospital admissions associated with short (...) , which had a 1.28% (95% confidence interval, 0.78%-1.78%) increase in risk per 10-microg/m3 increase in same-day PM2.5. Cardiovascular risks tended to be higher in counties located in the Eastern region of the United States, which included the Northeast, the Southeast, the Midwest, and the South.Short-term exposure to PM2.5 increases the risk for hospital admission for cardiovascular and respiratory diseases.

2006 JAMA

793. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. (Abstract)

Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Atherosclerosis and sepsis share several pathophysiological similarities, including immune dysregulation, increased thrombogenesis, and systemic inflammation. The relation between statins and risk of sepsis in patients with atherosclerosis is unknown.We did a population-based cohort analysis through linked administrative databases in Ontario, Canada, with accrual from 1997 to 2002. We identified (...) 141,487 patients older than 65 years who had been hospitalised for an acute coronary syndrome, ischaemic stroke, or revascularisation, who survived for at least 3 months after discharge. 46,662 (33%) were prescribed a statin within 90 days of discharge, 94,825 (67%) were not. Propensity-based matching, which accounted for each individual's likelihood of receiving a statin, yielded a cohort of 69,168 patients, of whom half (34,584) received a statin and half (34,584) did not.Incidence of sepsis

2006 Lancet

794. Physical activity for people with cardiovascular disease: recommendations of the National Heart Foundation of Australia Full Text available with Trip Pro

is available at the Heart Foundation website ( ). The recommendations provide health professionals with evidence-based physical activity information for specific cardiovascular conditions, including CHD, heart failure, stroke and peripheral vascular disease (PVD). There is NHMRC level I evidence (low risk of bias ) for the recommendations on CHD and heart failure, with lower levels of evidence for PVD and stroke (level II: moderate risk of bias), and for other cardiac conditions such as valvular heart (...) Physical activity for people with cardiovascular disease: recommendations of the National Heart Foundation of Australia Physical activity for people with cardiovascular disease: recommendations of the National Heart Foundation of Australia | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login

2006 MJA Clinical Guidelines

795. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. Full Text available with Trip Pro

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. Multiple epidemiologic studies and some trials have linked diet with cardiovascular disease (CVD) prevention, but long-term intervention data are needed.To test the hypothesis that a dietary intervention, intended to be low in fat and high in vegetables, fruits, and grains to reduce cancer, would reduce CVD risk.Randomized controlled trial of 48,835 (...) % of calories and increase intakes of vegetables/fruits to 5 servings/d and grains to at least 6 servings/d. The comparison group received diet-related education materials.Fatal and nonfatal coronary heart disease (CHD), fatal and nonfatal stroke, and CVD (composite of CHD and stroke).By year 6, mean fat intake decreased by 8.2% of energy intake in the intervention vs the comparison group, with small decreases in saturated (2.9%), monounsaturated (3.3%), and polyunsaturated (1.5%) fat; increases occurred

2006 JAMA Controlled trial quality: predicted high

796. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. (Abstract)

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Evidence-based treatment for hypercholesterolaemia in Japan has been hindered by the lack of direct evidence in this population. Our aim was to assess whether evidence for treatment with statins derived from western populations can be extrapolated to the Japanese population.In this prospective, randomised, open-labelled, blinded study, patients (...) with hypercholesterolaemia (total cholesterol 5.69-6.98 mmol/L) and no history of coronary heart disease or stroke were randomly assigned diet or diet plus 10-20 mg pravastatin daily. The primary endpoint was the first occurrence of coronary heart disease. Statistical analyses were done by intention to treat. This trial is registered at ClinicalTrials.gov, number NCT00211705.3966 patients were randomly assigned to the diet group and 3866 to the diet plus pravastatin group. Mean follow-up was 5.3 years. At the end

2006 Lancet Controlled trial quality: predicted high

797. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis Full Text available with Trip Pro

Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis Gaziano TA, Opie LH, Weinstein MC Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each (...) abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of two four-drug regimens for the primary and secondary prevention of cardiovascular disease in low- and middle-income countries. The authors concluded that the combination therapies reduced the risk of death from cardiovascular disease and were cost-effective, especially

2006 NHS Economic Evaluation Database.

798. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials

Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.

799. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.

800. Hormone therapy and cardiovascular disease: a systematic review and meta-analysis

Hormone therapy and cardiovascular disease: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.